Rayyan is an AI-assisted systematic review platform that helps research teams import, deduplicate, screen, extract data from, and report on literature across the full evidence synthesis workflow.
網站月造訪量估算
資料為該網域的 Similarweb 流量估算,不是活躍使用者數。僅顯示有資料的統計月份;擷取時間與流量統計月份分別標示。
擷取於 2026年11月11日

這是編輯給出的評估,滿分 5 分,不是使用者評分的平均值。 本頁的各方觀點由 AI 根據產品資訊歸納,不是真實使用者的評價。
依據 OpenAITools.app 於 2026-11-11 查驗的觀測資料,Rayyan(rayyan.ai)是收錄於 AI 研究工具的 AI 平台,每月產生 111.64萬次造訪,月流量變化量為 +8.19萬(+7.9%)。其主要地理市場為美國(流量佔比 18%),並採用免費增值定價模式。依每月流量計算的主要競爭替代方案包括 Elicit(每月 175.15萬次造訪),evidencepartners.com(每月 8776 次造訪),Paperguide(每月 37.2萬次造訪)。
系統性文獻回顧的神器,超強!
去重和篩選摘要省超多時間。
以下短評基於實時網頁探查、定價機制與同類基準由 AI 綜合生成,用於呈現不同情境下的常見亮點與槽點,非實名真實用戶留言。
The Systematic Auto-Resolver deduplicates up to 200,000 references using your own inclusion and exclusion protocol with one click.
ResearchPilot delivers zero-shot relevance ratings, an AI Analyzer, an AI Reviewer, and auto-extraction to speed up search, screening, and data capture.
Work through title, abstract, and full-text screening with inclusion and exclusion tagging, conflict resolution, and blinded reviewer modes.
Capture structured study data with configurable extraction fields, apply PICO frameworks, and export results with auto-generated PRISMA diagrams.
Randomly sample subsets, divide workloads, manage roles, and screen offline via the mobile app, with full audit trails for reproducibility.
Rayyan is an AI-assisted systematic review platform that helps research teams import, deduplicate, screen, extract data from, and report on literature across the full evidence synthesis workflow.
Run end-to-end reviews with deduplication, AI-assisted screening, data extraction, and PRISMA export in one platform.
Handle large reference sets with AI prioritization, risk-of-bias assessment, and audit-ready reporting.
Divide workloads across reviewers with sampling, roles, and conflict resolution on shared libraries.
Assess study quality with consistent Risk of Bias criteria and generate publication-ready outputs.
同一分類下同類 AI 工具的流量並排比較
| 排名 | AI 工具 | 每月造訪次數 | 月增幅 | 直接流量占比 | 價格 | 正面對決 |
|---|---|---|---|---|---|---|
| ● | Rayyan | 111.64萬 | +7.9% | 61% 直接流量 | 免費增值 | 目前產品 |
| 1 | Elicit 論文的自動化資料萃取與證據綜合能力較強,但較不專注於協作型標題與摘要篩檢工作流程。 | 175.15萬 | +3.1% | 49% 直接流量 | 免費增值 | 對比 Elicit |
| 2 | evidencepartners.com 提供企業級的系統性文獻回顧自動化與協定管理,但價格顯著較高且比 Rayyan 複雜。 | 8776 | -43.2% | 70% 直接流量 | 付費、需聯絡報價 | 對比 evidencepartners.com |
| 3 | Paperguide 提供扎實的文獻搜尋與參考文獻管理工具,但缺乏 Rayyan 專門的協作篩檢介面。 | 37.2萬 | -2.9% | 33% 直接流量 | 免費增值 | 對比 Paperguide |
| 4 | Scite 提供強大的引用分析與智慧引用指標,但較不適合完整的 PRISMA 系統性文獻回顧工作流程。 | 84.2萬 | +1.1% | 45% 直接流量 | 免費試用、需聯絡報價 | 對比 Scite |
| 5 | Consensus 很適合尋找科學共識與有證據支持的答案,但缺乏專屬的篩檢佇列與系統性文獻回顧萃取表單。 | 601.44萬 | -1.2% | 49% 直接流量 | 免費增值 | 對比 Consensus |
| 6 | SciSpace 非常適合閱讀、與之對話和摘要單篇論文,但對於多位審稿者的系統性文獻回顧篩檢而言,結構化程度較低。 | 446.41萬 | +8.6% | 29% 直接流量 | 免費增值 | 對比 SciSpace |

提供企業級的系統性文獻回顧自動化與協定管理,但價格顯著較高且比 Rayyan 複雜。
提供扎實的文獻搜尋與參考文獻管理工具,但缺乏 Rayyan 專門的協作篩檢介面。

專項更強Visualizes citation networks and paper relationships wonderfully, but lacks Rayyan's screening, tagging, and exclusion tracking features.
專項更強Visualizes citation networks and paper relationships wonderfully, but lacks Rayyan's screening, tagging, and exclusion tracking features.
專項更強Provides intuitive visual maps of academic literature connections, but doesn't support systematic review screening or data extraction.
專項更強Provides intuitive visual maps of academic literature connections, but doesn't support systematic review screening or data extraction.

免費 / 開源Provides a completely free and open academic search database, but lacks collaborative literature review screening tools.
免費 / 開源Provides a completely free and open academic search database, but lacks collaborative literature review screening tools.

專項更強Summarizes academic papers into interactive flashcards, but misses comprehensive systematic review screening pipelines.
專項更強Generates automated summaries of academic literature, but lacks Rayyan's collaborative team screening and evidence extraction tools.
專項更強Generates automated summaries of academic literature, but lacks Rayyan's collaborative team screening and evidence extraction tools.